Research Article
A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma
Figure 6
The role of HPRS in predicting the immunotherapy response and chemotherapy effect of LUAD. (a): The normalized expression (Log2 (FPKM + 1)) of immune checkpoints in high HPRS and low HPRS groups. (b): In TCGA (left), GSE31210 (center), and GSE50081 (right), the difference of TIDE score between high HPRS group and low HPRS group. (c): Estimated IC50 of paclitaxel, cisplatin, docetaxel, and vinorelbine in different HPRS groups. (d): Correlation between HPRS and estimated IC50 of paclitaxel, cisplatin, docetaxel, and vinorelbine. , , , .
(a) |
(b) |
(c) |
(d) |